(Q43856043)

27 November 2017

title

Expression of Polo-Like Kinase (PLK1) in non-Hodgkin's lymphomas (English)

1 reference

27 November 2017

Katsuhiko Mito

1

1 reference

27 November 2017

Kenji Kashima

2

1 reference

27 November 2017

Hiroshi Kikuchi

3

1 reference

27 November 2017

Tsutomu Daa

4

1 reference

27 November 2017

Iwao Nakayama

5

1 reference

27 November 2017

Shigeo Yokoyama

6

1 reference

27 November 2017

publication date

1 February 2005

1 reference

27 November 2017

1 reference

27 November 2017

volume

46

1 reference

27 November 2017

issue

2

1 reference

27 November 2017

page(s)

225-231

1 reference

Polo-like kinases: positive regulators of cell division from start to finish.

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190400015709

Polo-like kinases: a team that plays throughout mitosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400015709

polo encodes a protein kinase homolog required for mitosis in Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400015709

Induction and down-regulation of PLK, a human serine/threonine kinase expressed in proliferating cells and tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400015709

Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400015709

Expression of polo-like kinase in ovarian cancer is associated with histological grade and clinical stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400015709

Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400015709

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400015709

p53 and bcl-2 expression in high-grade B-cell lymphomas: correlation with survival time

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400015709

Antibody microinjection reveals an essential role for human polo-like kinase 1 (Plk1) in the functional maturation of mitotic centrosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400015709

Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400015709

Polo-like kinase (PLK) expression in endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400015709

Comparative expression of the mitotic regulators SAK and PLK in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400015709

Polo‐like kinase 1 (PLK1) is overexpressed in primary colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400015709

Prognostic clinicopathologic factors, including immunologic expression in diffuse large B-cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400015709

The role of reduced growth rate in the development of drug resistance of HOB1 lymphoma cells to vincristine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400015709

10.1080/10428190400015709

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference